Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Häufige urologisch-sexualmedizinische Themen in der Praxis sind das Thema des MMW-Webinars am 5. Juni von 17.30 bis 19 Uhr. Konkret geht es um die Frage, wann bei Harnwegsinfektionen auf Antibiotika verzichtet werden kann, und um ein Update zur Therapie von Libido- und Potenzstörungen des Mannes. Der dritte Vortrag behandelt sexuell übertragbare Krankheiten. Stellen Sie Ihre Fragen an die Experten und sammeln Sie 2 CME-Punkte. Jetzt gleich anmelden!
Erweiterte Suche
Anmelden
nach oben
Social Psychiatry and Psychiatric Epidemiology
Erschienen in: Social Psychiatry and Psychiatric Epidemiology 6/2009

01.06.2009 | ORIGINAL PAPER

Experiences of victimisation and depression are associated with community functioning among men with schizophrenia

verfasst von: Prof. Sheilagh Hodgins, Tania Lincoln, Tim Mak

Erschienen in: Social Psychiatry and Psychiatric Epidemiology | Ausgabe 6/2009

Einloggen, um Zugang zu erhalten

Abstract

Objectives

The present study aimed to identify proximal and distal factors associated with real life community functioning among men with schizophrenia. Real life community functioning was defined to include: independent living, occupational functioning, social and leisure activities, and substance misuse, self-harm, and aggressive behaviour.

Method

225 men with schizophrenia or schizo-affective disorder were assessed at discharge from hospital and at six-monthly intervals during a two-year period. Information was available from structured interviews with the participants, family members and treatment staff, records of psychiatric treatment, social service files, and official criminal records. Symptoms were assessed using the Positive and Negative Symptom Scale and the Hamilton Rating Scale for Depression. Substance misuse was measured by self-report and hair and urine analyses. Predictors of outcome were divided into four categories: childhood, adulthood, year prior to functional outcome assessment, and con-current.

Results

In a final regression model, five predictors were significantly associated with patients’ real life functioning: two adult life-time variables—a diagnosis of drug abuse/dependence and level of education and three current variables—victimisation, depression, and medication non-compliance. Most of the variance in the final outcome scores was explained by current predictors.

Discussion

In order to elevate levels of psychosocial functioning among men with schizophrenia, clinicians need to assess victimisation experiences, and, when present, design and implement interventions to help patients protect themselves. In addition, depression needs to be identified and treated, and compliance with antipsychotic medication assured.
Literatur
1.
Appelbaum PS, Robbins PC, Monahan J (2000) Violence and delusions: data from the MacArthur violence risk assessment study. Am J Psychiatry 157:566–572PubMedCrossRef
2.
Arseneault L, Moffitt TE, Caspi A, Taylor PJ, Silva PA (2000) Mental disorders and violence in a total birth cohort: results from the Dunedin study. Arch Gen Psychiatry 57:979–986PubMedCrossRef
3.
Belfrage A (1998) A ten-year follow-up of criminality in Stockholm mental patients: new evidence for a relation between mental disorder and crime. Br J Criminol 38(1):145–155
4.
Bhugra D, Leff J, Mallett R et al (1997) Incidence and outcome of schizophrenia in whites, African–Carribeans and Asians in London. Psychol Med 27(4):791–798PubMedCrossRef
5.
Bowie CR, Reichenberg A, Patterson TL et al (2006) Determinants of real-world functional performance in schizophrenia subjects: correlations with cognition, functional capacity, and symptoms. Am J Psychiatry 163(3):418–425PubMedCrossRef
6.
Brekke JS, Long JD (2000) Community-based psychosocial rehabilitation and prospective change in functional, clinical, and subjective experience variables in schizophrenia. Schizophr Bull 26(3):667–680PubMed
7.
Brennan P, Mednick SA, Hodgins S (2000) Major mental disorders and criminal violence in a Danish birth cohort. Arch Gen Psychiatry 57:494–500PubMedCrossRef
8.
Cantor-Graae E, Nordstrom L, McNeil TF (1971) Substance abuse in schizophrenia: a review of the literature and a study of correlates in Sweden. Schizophr Res 48:69–82CrossRef
9.
Dureman I, Kebbon L, Österberg E (1971) Manual till DS-batteriet. Stockholm, Sweden: Skandinaviska Testförlaget
10.
Efron B (1994) Missing data, imputation, and the bootstrap. J Am Stat Assoc 89:426, 463–475
11.
Erb M, Hodgins S, Freese R et al (2001) Homicide and schizophrenia: maybe treatment does have a preventive effect. Crim Behav Ment Health 11:6–26PubMedCrossRef
12.
Fazel S, Danesh J (2002) Serious mental disorder in 23,000 prisoners: a systematic review of 62 surveys. Lancet 359:545–550PubMedCrossRef
13.
First MB, Spitzer RL, Gibbon M, et al (1996) Structured clinical interview for axes I and II DSM-IV disorders-patient edition. Biometrics Research Department. New York State Psychiatric Institute, New York
14.
Gaite L, Vâzquez-Barquero JL, Herrân A et al (2005) Main determinants of global assessment of functioning score in schizophrenia: a European multi-center study. Compr Psychiatry 46(6):440–446PubMedCrossRef
15.
Green B, Young R, Kavanagh D (2005) Cannabis use and misuse prevalence among people with psychosis. Br J Psychiatry 187:306–313PubMedCrossRef
16.
Hambrecht M, Häfner H (1996) Substance abuse and the onset of schizophrenia. Biol Psychiatry 40:1155–1163PubMedCrossRef
17.
18.
Healy D, Harris M, Tranter R et al (2006) Lifetime suicide rates in treated schizophrenia: 1975–1924 and 1994–1998 cohorts compared. Br J Psychiatry 188:223–228PubMedCrossRef
19.
Henry AD, Coster WJ (1996) Predictors of functional outcome among adolescents and young adults with psychotic disorders. Am J Occup Ther 50:171–181PubMed
20.
Hiday VA, Swartz MS, Swanson JW et al (2002) Impact of outpatient commitment on vicitimization of people with severe mental illness. Am J Psychiatry 159(8):1403–1411PubMedCrossRef
21.
Hodgins S, Alderton J, Cree A et al (2007) Aggressive behaviour, victimisation, and crime among severely mentally ill patients requiring hospitalisation. Br J Psychiatry 191:343–350PubMedCrossRef
22.
Hodgins S (1998) Epidemiological investigations of the associations between major mental disorders and crime: methodological limitations and validity of the conclusions. Soc Psychiatry Psychiatr Epidemiol 33(Suppl 1):S20–S37
23.
Hodgins S, Hiscoke UL, Freese R (2003) The antecedents of aggressive behavior among men with schizophrenia: a prospective investigation of patients in community treatment. Behav Sci Law 21:523–546PubMedCrossRef
24.
Hodgins S, Müller-Isberner R (2004) Preventing crime by people with schizophrenic disorders: the role of psychiatric services. Br J Psychiatry 185:245–250PubMedCrossRef
25.
Hodgins S, Tiihonen J, Ross D (2005) The consequences of conduct disorder for males who develop schizophrenia: associations with criminality, aggressive behaviour, substance use, and psychiatric services. Schizophr Res 78:323–335PubMedCrossRef
26.
Hoffer A, Rettenbacher MA, Widchscwendter ChG et al (2006) Correlates of subjective and functional outcomes in outpatient clinic attendees with schizophrenia and schizoaffective disorder. Eur Arch Psychiatry Clin Neurosci 256:246–255CrossRef
27.
Kay SR, Fiszbein A, Opler LA (1987) The Positive And Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 13(2):261–276PubMed
28.
Link BG, Steuve A, Phelan J (1998) Psychotic symptoms and violent behaviors: probing the components of “threat/control/override” symptoms. Soc Psychiatry Psychiatr Epidemiol 33(Suppl 1):S55–S60PubMedCrossRef
29.
Margolese HC, Negrete JC, Tempier R et al (2006) A 12-month prospective follow-up study of patients with schizophrenia-spectrum disorders and substance abuse: changes in psychiatric symptoms and substance use. Schizophr Res 83(1):65–75PubMedCrossRef
30.
McKibbon C, Patterson TL, Jeste DV (2004) Assessing disability in older patients with schizophrenia results from the WHODAS-II. J Nerv Ment Dis 192(6):405–413CrossRef
31.
Mojtabai R (2006) Psychotic-like-experiences and interpersonal violence in the general population. Soc Psychiatry Psychiatr Epidemiol 41:183–190PubMedCrossRef
32.
Monahan J, Steadman HJ, Silver E et al (2001) Rethinking risk assessment: the Macarthur study of mental disorder and violence. Oxford University Press, New York
33.
Naudts K, Hodgins S (2006) Neurobiological correlates of violent behaviour among persons with schizophrenia. Schizophr Bull 32(3):562–572PubMedCrossRef
34.
O’Maila L, McFarland BH, Barker S et al (2002) A level-of-functioning self-report measure for consumers with severe mental illness. Psychiatr Serv 53(3):326–331CrossRef
35.
Odgers CL, Caspi A, Broadbent JM et al (2007) Prediction of differential adult health burden by conduct problem subtypes in males. Arch Gen Psychiatry 64:476–484PubMedCrossRef
36.
Palmer BA, Pankratz VS, Bostwick JM (2005) The life-time risk of suicide in schizophrenia: a re-examination. Arch Gen Psychiatry 62:247–253PubMedCrossRef
37.
Radomsky ED, Haas GL, Mann JJ et al (1999) Suicidal behaviour in patients with schizophrenia and other psychotic disorders. Am J Psychiatry 156:1590–1595PubMed
38.
Read J, Goodman L, Morrison AP (2004) Childhood trauma, loss and stress. In: Read J, Mosher LR, Bentall RP et al (eds) Models of madness. Routledge, London
39.
Regier DA, Farmer ME, Rae DS et al (1990) Comorbidity of mental disorders with alcohol and other drug abuse: results from the epidemiological catchment area (ECA) study. JAMA 264(19):2511–2518PubMedCrossRef
40.
Rosenheck R, Leslie D, Keefe R et al (2006) Barriers to employment for people with schizophrenia. Am J Psychiatry 163(3):411–417PubMedCrossRef
41.
Shahar G, Wisher A, Chinnman M et al (2004) Trauma and adaptation in severe mental illness: the role of self-reported abuse and exposure to community violence. J Trauma Dissociation 5(1):29–47CrossRef
42.
Silver E, Arseneault L, Langley J et al (2005) Mental disorder and violent victimization in a total birth cohort. Am J Public Health 95:2015–2021PubMedCrossRef
43.
Slaton KD, Westphal JR (1999) The Slaton–Westphal functional assessment inventory for adults with psychiatric disability: development of an instrument to measure functional status and psychiatric rehabilitation outcome. Psychiatr Rehab J 23(2): 119–126
44.
Steadman HJ, Mulvey EP, Monahan J et al (1998) Violence by people discharged from acute psychiatric inpatient facilities and by others in the same neighborhoods. Arch Gen Psychiatry 55:393–401PubMedCrossRef
45.
Straus JS, Carpenter WT (1972) The prediction of outcome in schizophrenia. Arch Gen Psychiatry 27:739–746
46.
Swanson JW, Swartz MS, Van Dorn RA et al (2006) A national study of violent behaviour in persons with schizophrenia. Arch Gen Psychiatry 63:490–499PubMedCrossRef
47.
Swartz MS, Wagner HR, Swanson JW et al (2006) Substance use and psychosocial functioning in schizophrenia among new enrollees in the NIMH CATIE study. Psychiatr Ser 57:1110–1116CrossRef
48.
Teplin L, McClelland GM, Abram KM et al (2005) Crime victimization in adults with severe mental illness; comparison with the national crime victimization survey. Arch Gen Psychiatry 62:911–921PubMedCrossRef
49.
Tiihonen J, Isohanni M, Räsänen P et al (1997) Specific major mental disorders and criminality: a 26-year prospective study of the 1966 Northern Finland birth cohort. Am J Psychiatry 154(6):840–845PubMed
50.
Verma SK, Subramaniam M, Chong S-A et al (2002) Substance abuse in schizophrenia: a Singapore perspective. Soc Psychiatry Psychiatr Epidemiol 37(7):326–328PubMedCrossRef
51.
Vevera J, Hubbard A, Vesel Y et al (2005) Violent behaviour in schizophrenia. Br J Psychiatry 187:426–430PubMedCrossRef
52.
Volavka J, Laska E, Baker S et al (1997) History of violent behaviour and schizophrenia in different cultures: analyses based on the WHO study on determinants of outcome of severe mental disorders. Br J Psychiatry 171:9–14PubMedCrossRef
53.
Wallace C, Mullen PE, Burgess P (2004) Criminal offending in schizophrenia over a 25-year period marked by deinstitutionalization and increasing prevalence of comorbid substance use disorders. Am J Psychiatry 161(4):716–727PubMedCrossRef
54.
Walsh E, Moran P, Scott C et al (2003) Prevalence of violent victimisation in severe mental illness. Br J Psychiatry 183:233–238PubMedCrossRef
55.
Wechsler D (1981) Wechsler adult intelligence test—revised. Psychological Corporation, New York
56.
Westermeyer J (2006) Comorbid schizophrenia and substance abuse: a review of epidemiology and course. Am J Addict 15(5):345–355PubMedCrossRef
57.
Wykes T, Stuart E (1986) The measurement of social behaviour in psychiatric patients: an assessment of the reliability and validity of the SBS schedule. Br J Psychiatry 148:1–11PubMedCrossRef
Metadaten
Titel
Experiences of victimisation and depression are associated with community functioning among men with schizophrenia
verfasst von
Prof. Sheilagh Hodgins
Tania Lincoln
Tim Mak
Publikationsdatum
01.06.2009
Erschienen in
Social Psychiatry and Psychiatric Epidemiology / Ausgabe 6/2009
Print ISSN: 0933-7954
Elektronische ISSN: 1433-9285
DOI
https://doi.org/10.1007/s00127-008-0460-8

Weitere Artikel der Ausgabe 6/2009

Social Psychiatry and Psychiatric Epidemiology 6/2009 Zur Ausgabe

ORIGINAL PAPER

U.S. military mental health care utilization and attrition prior to the wars in Iraq and Afghanistan

ORIGINAL PAPER

Attitudes and beliefs of patients of first episode depression towards antidepressants and their adherence to treatment

ORIGINAL PAPER

Are people with dental fear under-represented in oral epidemiological surveys?

ORIGINAL PAPER

Variations in rates of comorbid substance use in psychosis between mental health settings and geographical areas in the UK

ORIGINAL PAPER

Social phobia in Nigerian university students: prevalence, correlates and co-morbidity

ORIGINAL PAPER

Is childhood pain associated with future mental health problems?

Neu im Fachgebiet Psychiatrie

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

29.05.2024 Hörstörungen Nachrichten

Hört jemand im Alter schlecht, nimmt das Hirn- und Hippocampusvolumen besonders schnell ab, was auch mit einem beschleunigten kognitiven Abbau einhergeht. Und diese Prozesse scheinen sich unabhängig von der Amyloidablagerung zu ereignen.

So wirken verschiedene Alkoholika auf den Blutdruck

23.05.2024 Störungen durch Alkohol Nachrichten

Je mehr Alkohol Menschen pro Woche trinken, desto mehr steigt ihr Blutdruck, legen Daten aus Dänemark nahe. Ob es dabei auch auf die Art des Alkohols ankommt, wurde ebenfalls untersucht.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise